Antonio Marra

4.7k total citations · 3 hit papers
112 papers, 2.5k citations indexed

About

Antonio Marra is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Antonio Marra has authored 112 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 33 papers in Cancer Research. Recurrent topics in Antonio Marra's work include Cancer Genomics and Diagnostics (24 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (23 papers). Antonio Marra is often cited by papers focused on Cancer Genomics and Diagnostics (24 papers), HER2/EGFR in Cancer Research (23 papers) and Advanced Breast Cancer Therapies (23 papers). Antonio Marra collaborates with scholars based in Italy, United States and France. Antonio Marra's co-authors include Giuseppe Curigliano, Giulia Viale, Dario Trapani, Carmen Criscitiello, Stefania Morganti, Paolo Tarantino, Giuseppe Viale, Emanuela Ferraro, Sara M. Tolaney and Javier Cortes and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Antonio Marra

109 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER2-Low Breast Cancer: Pathological and Clinical Landscape

2020 490 citations Paolo Tarantino, Erika Hamilton et al. Journal of Clinical Oncology profile →
Evolution of low HER2 expression between early and advanced-stage breast cancer

2022 121 citations Paolo Tarantino, Eleonora Nicolò et al. European Journal of Cancer profile →
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives

2024 45 citations Antonio Marra, Sarat Chandarlapaty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Marra Italy	24	1.5k	684	682	523	403	112	2.5k
Mukund Seshadri United States	29	987 0.7×	979 1.4×	573 0.8×	1.1k 2.1×	352 0.9×	109	3.7k
Chiara Corti Italy	25	1.3k 0.8×	442 0.6×	334 0.5×	466 0.9×	458 1.1×	70	1.9k
Paolo Tarantino Italy	28	2.3k 1.5×	826 1.2×	777 1.1×	632 1.2×	1000 2.5×	128	3.2k
Lorenzo Trippa United States	28	875 0.6×	351 0.5×	680 1.0×	829 1.6×	299 0.7×	120	2.8k
Alessandro Russo Italy	31	1.5k 1.0×	1.4k 2.0×	840 1.2×	872 1.7×	235 0.6×	125	2.7k
Zefei Jiang China	30	2.5k 1.6×	1.2k 1.8×	915 1.3×	1.1k 2.2×	744 1.8×	198	3.8k
Subha Madhavan United States	30	1.1k 0.7×	511 0.7×	1.2k 1.8×	1.5k 2.8×	234 0.6×	113	3.2k
Toby C. Cornish United States	30	1.4k 0.9×	768 1.1×	700 1.0×	1.2k 2.2×	247 0.6×	75	3.6k
Xiaosong Chen China	30	1.5k 1.0×	381 0.6×	1.3k 1.9×	924 1.8×	588 1.5×	163	3.2k
Debasish Tripathy United States	21	1.7k 1.1×	484 0.7×	1.2k 1.7×	778 1.5×	538 1.3×	54	2.8k

Countries citing papers authored by Antonio Marra

Since Specialization

Citations

This map shows the geographic impact of Antonio Marra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Marra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Marra more than expected).

Fields of papers citing papers by Antonio Marra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Marra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Marra. The network helps show where Antonio Marra may publish in the future.

Co-authorship network of co-authors of Antonio Marra

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Marra. A scholar is included among the top collaborators of Antonio Marra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Marra. Antonio Marra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Yanyan, Fan Wu, HuiYong Zhao, et al.. (2025). Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers. Science Translational Medicine. 17(801). eadk7786–eadk7786. 2 indexed citations

Venetis, Konstantinos, Chiara Frascarelli, Luca Boscolo Bielo, et al.. (2025). Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact. European Journal of Cancer. 217. 115233–115233. 9 indexed citations

Cursano, Giulia, Mariia Ivanova, Chiara Frascarelli, et al.. (2025). Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer. Molecular Diagnosis & Therapy. 29(6). 849–857.

Bielo, Luca Boscolo, Matteo Repetto, Edoardo Crimini, et al.. (2024). Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The Oncologist. 29(7). 560–565. 2 indexed citations

Antonarelli, Gabriele, Chiara Corti, Paolo Tarantino, et al.. (2023). Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure. ESMO Open. 8(4). 101608–101608. 21 indexed citations

Mandelker, Diana, Antonio Marra, Nikita Mehta, et al.. (2023). Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. npj Precision Oncology. 7(1). 34 indexed citations

Irani, Seema, Qing Li, Weiyi Toy, et al.. (2023). Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. Journal of Clinical Investigation. 134(1). 9 indexed citations

Weigelt, Britta, Antonio Marra, Pier Selenica, et al.. (2023). Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications. Cancer Discovery. 13(11). 2356–2369. 19 indexed citations

Derakhshan, Fatemeh, Arnaud Da Cruz Paula, Pier Selenica, et al.. (2023). Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization. Modern Pathology. 37(2). 100375–100375. 4 indexed citations

10.

Ferraro, Emanuela, Anton Safonov, Yuan Chen, et al.. (2023). Abstract P4-02-01: Efficacy of HER2 ADCs against HER2 inhibitor resistance alterations in the PI3K and MAPK pathways in HER2-positive breast cancer. Cancer Research. 83(5_Supplement). P4–2. 2 indexed citations

11.

Morganti, Stefania, Antonio Marra, Edoardo Crimini, et al.. (2022). Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?. Breast Cancer Research and Treatment. 192(3). 465–484. 9 indexed citations

12.

Marra, Antonio, Giulia Viale, Stefano Pileri, et al.. (2020). Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treatment Reviews. 84. 101963–101963. 54 indexed citations

13.

Duso, Bruno A., Dario Trapani, Antonio Marra, et al.. (2020). Pharmacological management of male breast cancer. Expert Opinion on Pharmacotherapy. 21(12). 1493–1504. 7 indexed citations

14.

Tarantino, Paolo, Erika Hamilton, Sara M. Tolaney, et al.. (2020). HER2-Low Breast Cancer: Pathological and Clinical Landscape. Journal of Clinical Oncology. 38(17). 1951–1962. 490 indexed citations breakdown →

15.

Zattarin, Emma, Chiara Fabbroni, Francesca Ligorio, et al.. (2020). 300P Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study. Annals of Oncology. 31. S362–S363. 2 indexed citations

16.

Marra, Antonio, Fabio Martinelli, Paolo Mori, et al.. (2019). Enhancing Security in ETSI Open Source MANO with Usage Control Capability. Immunotechnology. 25–29. 3 indexed citations

17.

Viale, Giulia, Antonio Marra, Giuseppe Curigliano, & Carmen Criscitiello. (2019). Toward precision medicine in inflammatory breast cancer. Translational Cancer Research. 8(6). 1 indexed citations

18.

Curigliano, Giuseppe, Vincenzo Bagnardi, Jamila Louahed, et al.. (2019). Expression of tumor-associated antigens in breast cancer subtypes. The Breast. 49. 202–209. 26 indexed citations

19.

Marra, Antonio, Giuseppe Viale, Dario Trapani, et al.. (2019). Predictive role of derived neutrophil to lymphocyte ratio on platinum-based chemotherapy in triple-negative breast cancer. Annals of Oncology. 30. iii61–iii61. 1 indexed citations

20.

Marra, Antonio, Cristina R. Ferrone, Giosuè Scognamiglio, et al.. (2017). Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives. Anti-Cancer Agents in Medicinal Chemistry. 18(2). 166–181. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact